Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03072160
Brief Title: Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer

First Submitted : March 3, 2017
First Submitted that Met QC Criteria : March 3, 2017
First Posted : March 7, 2017

Last Update Submitted that Met QC Criteria : August 21, 2019
Last Update Posted : August 22, 2019